We are live on
!
Find out more
NA
NewEdge Advisors Portfolio holdings
AUM
$27.7B
1-Year Est. Return
22.98%
This Fund
S&P 500
This Quarter
Est. Return
+6.1%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$8.85B
AUM Growth
+$851M
(+11%)
Cap. Flow
+$412M
Cap. Flow
% of AUM
4.65%
Top 10 Holdings %
Top 10 Hldgs %
16.84%
Holding
3,702
New
289
Increased
1,323
Reduced
1,138
Closed
218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$30.8M |
| 2 |
Unilever
UL
|
+$28.5M |
| 3 |
Comcast
CMCSA
|
+$27.6M |
| 4 |
Illinois Tool Works
ITW
|
+$27.1M |
| 5 |
Mondelez International
MDLZ
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$30.6M |
| 2 |
Abbott
ABT
|
+$28.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$27.8M |
| 4 |
Dover
DOV
|
+$27.1M |
| 5 |
State Street Ultra Short Term Bond ETF
ULST
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.26% |
| 2 | Financials | 5.78% |
| 3 | Healthcare | 5.7% |
| 4 | Consumer Discretionary | 4.46% |
| 5 | Industrials | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
ResMed
RMD
$30.6B
| $46.9K | ﹤0.01% |
215
+83
| +63% | +$18.5K |
|
2102
ProShares UltraPro S&P 500
UPRO
$5.23B
| $46.6K | ﹤0.01% |
984
| – | – |
|
2103
Myers Industries
MYE
$1.29B
| $46.6K | ﹤0.01% |
2,398
+508
| +27% | +$9.98K |
|
2104
Labcorp
LH
$25B
| $46.5K | ﹤0.01% |
225
-4,411
| -95% | -$856K |
|
2105
Leidos
LDOS
$14.5B
| $46.4K | ﹤0.01% |
524
-170
| -24% | -$14.5K |
|
2106
GATX Corp
GATX
$6.35B
| $46.2K | ﹤0.01% |
359
+17
| +5% | +$1.99K |
|
2107
Essential Utilities
WTRG
$11.3B
| $46.1K | ﹤0.01% |
1,156
-119
| -9% | -$4.99K |
|
2108
Global X S&P 500 Catholic Values ETF
CATH
$1.28B
| $46.1K | ﹤0.01% |
847
-19
| -2% | -$978 |
|
2109
Whirlpool
WHR
$2.43B
| $45.9K | ﹤0.01% |
309
-266
| -46% | -$36.5K |
|
2110
Live Nation Entertainment
LYV
$40.6B
| $45.6K | ﹤0.01% |
500
+69
| +16% | +$5.39K |
|
2111
WEX
WEX
$6.37B
| $45.5K | ﹤0.01% |
250
| – | – |
|
2112
Darling Ingredients
DAR
$9.64B
| $45.2K | ﹤0.01% |
709
| – | – |
|
2113
ENDRA Life Sciences
NDRA
$5.97M
| $45.2K | ﹤0.01% |
18
-1
| -5% | -$2.82K |
|
2114
CBAK Energy Technology Ltd
CBAT
$44.3M
| $45.1K | ﹤0.01% |
37,000
| – | – |
|
|
DISH
2115
DELISTED
DISH Network Corp.
DISH
| $45K | ﹤0.01% |
+6,830
| New | +$48.4K |
|
2116
Yum China
YUMC
$16.5B
| $44.8K | ﹤0.01% |
794
-17,727
| -96% | -$1.07M |
|
2117
Schwab US REIT ETF
SCHH
$11.5B
| $44.7K | ﹤0.01% |
2,289
-783
| -25% | -$15K |
|
2118
COPT Defense Properties
CDP
$4.3B
| $44.6K | ﹤0.01% |
1,879
-685
| -27% | -$16K |
|
2119
Eastman Chemical
EMN
$8B
| $44.6K | ﹤0.01% |
533
+11
| +2% | +$894 |
|
2120
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.94B
| $44.6K | ﹤0.01% |
2,392
+143
| +6% | +$2.65K |
|
2121
Biomerica
BMRA
$4.6M
| $44.5K | ﹤0.01% |
4,088
| – | – |
|
2122
Wabtec
WAB
$49.1B
| $44.4K | ﹤0.01% |
405
+55
| +16% | +$5.46K |
|
|
UCTT
2123
Ultra Clean Holdings
UCTT
$3.73B
| $44.2K | ﹤0.01% |
1,148
-190
| -14% | -$6.11K |
|
2124
Ryanair
RYAAY
$30.4B
| $44K | ﹤0.01% |
995
+7
| +0.7% | +$282 |
|
2125
Virco
VIRC
$95.2M
| $43.8K | ﹤0.01% |
10,503
| – | – |
|
Similar funds
FDCDDQ
TWC
N
PCH
PAM
WP
NewEdge Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, NewEdge Advisors held 3,702 positions worth $8.85B, up 11% from $8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
NewEdge Advisors deployed $412M of net new capital in Q2 2023, opening 289 new positions and adding to 1,323 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Accenture, an estimated $30.6M trimmed.
- NewEdge Advisors's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
- NewEdge Advisors added most to AbbVie in Q2 2023, an estimated $30.8M increase.
- NewEdge Advisors's biggest Q2 2023 reduction was Accenture, cutting an estimated $30.6M.
- NewEdge Advisors fully exited Quadratic Deflation ETF in Q2 2023, selling an estimated $3.13M.
- NewEdge Advisors's ten largest holdings make up 17% of its $8.85B portfolio in Q2 2023.
- NewEdge Advisors opened 289 new positions and closed 218 in Q2 2023.
- NewEdge Advisors's portfolio value rose 11% quarter-over-quarter to $8.85B.
Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.